Որոնման արդյունքները - Faramarz Ismail‐Beigi
- Ցուցադրվում են 1 - 20 արդյունքները 50
- Գնացեք Հաջորդ էջ
-
1
Clinical Implications of the ACCORD Trial Saul Genuth, Faramarz Ismail‐Beigi
Հրապարակվել է 2011Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials Sepehr Gohari, Faramarz Ismail‐Beigi, Mahsa Mahjani, Saeed Ghobadi, Alireza Jafari, Hassan Ahangar, Sheida Gohari
Հրապարակվել է 2023Revisão -
18
Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial Hoda Taheri, Mojtaba Malek, Faramarz Ismail‐Beigi, Farhad Zamani, Masoudreza Sohrabi, Mohammad Reza Babaei, Mohammad E. Khamseh
Հրապարակվել է 2020Artigo -
19
-
20
Որոնման գործիքներ:
Առնչվող խորագիր
Endocrinology
Medicine
Internal medicine
Diabetes mellitus
Type 2 diabetes
Insulin
Biology
Chemistry
Intensive care medicine
Biochemistry
Insulin resistance
Randomized controlled trial
Confidence interval
Disease
Glycemic
Gene
Alternative medicine
Hazard ratio
Hypoglycemia
Organic chemistry
Pathology
Placebo
Cardiology
Cell biology
Environmental health
Kidney disease
Population
Diabetic retinopathy
Empagliflozin
Engineering